In clinical trials of Wegovy (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise
GHK-based formulations, including nanoparticle conjugates, hydrogels, and clinical derivatives such as TriHex and TriHex 2.0, enhance fibroblast migration, ECM remodeling, collagen and elastin synthesis, and wound closure while providing antimicrobial activity
GHK-Cu CERTIFICATES OF ANALYSIS 6 COAs BN-26GK100-001 Current Variant: Size: 100mg GHK-Cu 108.66 mg / 121.23 mg Purity 99.739% / 99.744% BN-26GK50-001 Upcoming Variant: Size: 50mg Total GHK-Cu Content 60.26 mg / 62.5 mg GHK Content 50.27 mg / 52.07 mg Copper (Cu) Content 9.99 mg / 10.43 mg Purity 99.945% / 99.919% BN-25GK100-002 Previous Variant: Size: 100mg BN-25GK100-001 Previous Variant: Size: 100mg BN-25GK50-002 Previous Variant: Size: 50mg BN-24GK100-001 Previous Variant: Size: 100mg Small-Batch Research Confidence Focused research supply, documented batch by batch
Three out of four people on prednisone or prednisolone will gain weight, sometimes 10 pounds, sometimes closer to 30
(2018, January 16)
